Apyx Medical (APYX) EBT (2011 - 2026)

Apyx Medical has reported EBT for 16 years, with the latest figure at -$2.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 51.49% year-over-year to -$2.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 12.37% YoY), and the FY2025 full-year result was $3.0 million, up 23.01% from the prior year.
• EBT for Q1 2026 stood at -$2.0 million, down from $12.7 million in the prior quarter.
• The five-year high for EBT was $21.2 million in Q4 2024, with the low at -$9.5 million in Q4 2023.
• Historically, EBT has averaged -$2.4 million across 5 years, with a median of -$5.0 million in 2023.
• The largest YoY upside for EBT was 322.21% in 2024 against a maximum downside of 585.83% in 2024.
• Apyx Medical's EBT stood at -$5.9 million in 2022, then slumped by 61.26% to -$9.5 million in 2023, then soared by 322.21% to $21.2 million in 2024, then plunged by 40.03% to $12.7 million in 2025, then slumped by 115.74% to -$2.0 million in 2026.
• The last three EBT figures came in at -$2.0 million (Q1 2026), $12.7 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.